Current:Home > NewsCDC advisers back broad rollout out of new COVID boosters -Wealth Nexus Pro
CDC advisers back broad rollout out of new COVID boosters
View
Date:2025-04-16 10:20:42
A panel of advisers to the Centers for Disease Control and Prevention backed the broad use of new COVID-19 vaccines, as cases of the respiratory illness rise.
The advisers voted 13-1 to recommend the vaccines for people ages 6 months and older. While the benefits appear to be greatest for the oldest and youngest people, the benefits of vaccination exceed the risks for everyone, according to a CDC analysis.
The universal recommendation, as opposed to one that applies to selected groups, could ease the rollout of the vaccine and improve access and equity.
"Let's keep America strong, healthy," said Dr. Camille Kotton, a panel member who voted in favor of the recommendation and who is an infectious disease specialist at Harvard Medical School. "Let's do away with COVID-19 as best we can by prevention of disease through vaccines. Let's make things clear."
The Food and Drug Administration gave the go-ahead to vaccines from Moderna and Pfizer-BioNTech Monday. A new vaccine from Novavax is under FDA review and may be approved soon.
The new vaccines target a much more recent variant of the omicron strain called XBB.1.5 that was selected by the FDA in June for use in formulating new vaccines. The idea, akin to how flu vaccines are made, is to match a seasonal vaccine to the virus that is infecting people.
Since the FDA's decision, other variants have overtaken XBB.1.5, but laboratory data suggest the new vaccines should provide good protection against COVID-19, including serious illness, hospitalization and death. The new shots can bolster immunity from previous vaccinations and COVID illness.
The last step before vaccination with the new shots can start is a formal decision by the CDC director. The decision is expected to quickly follow the panel's vote.
The new shots could become available as soon as Wednesday in some parts of the country. They're not technically free anymore, but for most people insurance will pay for them. The federal government will make the shots available for the uninsured at no cost.
veryGood! (51)
Related
- Juan Soto to be introduced by Mets at Citi Field after striking record $765 million, 15
- 'Oppenheimer' sex scene with Cillian Murphy sparks backlash in India: 'Attack on Hinduism'
- Ranking Oil Companies by Climate Risk: Exxon Is Near the Top
- Iam Tongi Wins American Idol Season 21
- Rylee Arnold Shares a Long
- Iam Tongi Wins American Idol Season 21
- Baltimore Ravens WR Odell Beckham Jr. opens up on future plans, recovery from ACL injury
- EPA’s Methane Estimates for Oil and Gas Sector Under Investigation
- Newly elected West Virginia lawmaker arrested and accused of making terroristic threats
- MLB power rankings: Orioles in rare air, knocking Rays out of AL East lead for first time
Ranking
- What to watch: O Jolie night
- U.S. charges El Chapo's sons and other Sinaloa cartel members in fentanyl trafficking
- Jennifer Lawrence Showcases a Red Hot Look at 2023 Cannes Film Festival
- The Politics Of Involuntary Commitment
- A Mississippi company is sentenced for mislabeling cheap seafood as premium local fish
- Share your story: Have you used medication for abortion or miscarriage care?
- Attacks on Brazil's schools — often by former students — spur a search for solutions
- 146 dogs found dead in home of Ohio dog shelter's founding operator
Recommendation
Highlights from Trump’s interview with Time magazine
Pipeline Payday: How Builders Win Big, Whether More Gas Is Needed or Not
Transcript: Former New Jersey Gov. Chris Christie on Face the Nation, June 18, 2023
An Arctic Offshore Drilling Plan Advances, but Impact Statement Cites Concerns
San Francisco names street for Associated Press photographer who captured the iconic Iwo Jima photo
A rehab center revives traumatized Ukrainian troops before their return to battle
Federal appeals court preserves access to abortion drug but with tighter rules
The dream of wiping out polio might need a rethink